Bioresonance POLAR PS 1000
Rayonex's philosophy is to maximize the benefits of Bioresonance Therapy (BRT) for patients while minimizing the workload for therapists. Today, it is crucial to use treatment methods that are safe, fast, and precise. Treatment should not harm patients, and the positive effects should be supported by scientific research. Rayonex Biomedical GmbH in Lennestadt, Germany, drawing on 33 years of work and research, has developed the Polar PS 1000 Rayocomp device. The Polar PS 1000 is a bioresonance device for therapy and diagnostics.
Previously, bioresonance diagnostics and therapy were time-consuming and required a lot of effort, which led many patients to discontinue treatment even when they experienced positive results. Rayonex aimed to change this situation and developed Rayoscan software that automatically calculates therapeutic frequencies in less than 15 minutes, receiving signals from electrocardiographic electrodes.
Rayoscan collects, processes data, and calculates results using ECG screening. Within 12-15 minutes, it tests 200 different frequencies and their therapeutic importance. Then, it displays a list of suitable therapeutic programs sorted by priority.
To perform the procedure, a therapist attaches 4 ECG sensors to the patient's body and begins scanning. During the scan, the patient sees test results, ECG images, and pulse data on the device's screen, making the procedure comfortable and understandable.
This testing approach is highly sensitive and can detect diseases at the earliest stages, even before symptoms manifest. After 15 minutes, the harmonization programs provide results with the names of specific organic disorders and diseases.
This method is completed 8 times faster than conventional diagnostic methods, minimizing the human factor. Arrhythmia and cardiac pacemakers do not affect the procedure. There are no contraindications to using this procedure.
The Polar PS 1000 device can store up to 1000 patient histories. Therapy programs for each patient can be saved on a Green Card, allowing patients to continue treatment at home using the mobile PS 10 device. Combining stationary and mobile devices enables diagnostic and initial treatment during the first visit. Patients can then continue treatment via their own Green Card inserted into the PS 10. This approach increases the efficiency of doctors' work and reduces patients' treatment time.
The effectiveness of this method is supported by in vitro laboratory research and in vivo clinical studies conducted at the DARTSCH scientific institute and the FRAUENHOFER institute in Germany. Polar PS 1000 is a safe, fast, and accurate diagnostic and therapeutic method.